John L. Higgins, Chief Executive Officer at LIGAND PHARMACEUTICALS INC (LGND), sold 112,302 shares at $203.40 ($22.8M) on 2021-02-05, disclosed to the SEC on 2021-02-09.
Seasonal sale ($22.8M) by Chief Executive Officer — this insider has traded LGND in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $203.03 | 2,970 | $603K | 2.6% |
| 2 | $203.40 | 54,666 | $11.1M | 48.7% |
| 3 | $203.40 | 54,666 | $11.1M | 48.7% |
| Total | $203.39 avg | 112,302 | $22.8M | 100% |
| Filing → |
| OABI | BUY | 2025-03-21 | $9K | — | Filing → |
| OABI | BUY | 2025-03-20 | $591K | — | Filing → |
| TECH | SELL | 2024-05-16 | $335K | — | Filing → |